References
- Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use. Results from the National Health and Nutrition Examination Survey, 1999–2010. Obstet Gynecol 2012;120:595–603
- Fenton A, Panay N. The Women’s Health Initiative – a decade of progress. Climacteric 2012;15:205
- Wolff EF, He Y, Black DM, Brinton EA. Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril 2013;99:1385–91
- Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomized trial. BMJ 2012;345: e6409
- Ruan X, Seeger H, Mueck AO. Breast cancer risk during hormone therapy: experimental versus clinical data. Minerva Endocrinol 2012;37:59–74
- Panay N, Fenton A. Has the time for the definitive, randomized, placebo-controlled HRT trial arrived? Climacteric 2011;14: 195–6
- de Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316–37